ornithine has been researched along with Cardiovascular Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
Auge, D; Chafai, A; Fromm, MF; Gessner, A; Maas, R; Mieth, M; Müller, F | 1 |
Eitzman, DT; Hodgin, JB; Kaplan, MJ; Knight, JS; Luo, W; O'Dell, AA; Subramanian, V; Thompson, PR; Yalavarthi, S; Zhao, W | 1 |
Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z | 1 |
Emanueli, C; Fortunato, O; Madeddu, P; Mangialardi, G; Monopoli, A; Ongini, E; Spinetti, G | 1 |
Boehm, BO; Grammer, TB; März, W; Meinitzer, A; Pilz, S; Sourij, H; Winkelmann, BR | 1 |
6 other study(ies) available for ornithine and Cardiovascular Diseases
Article | Year |
---|---|
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
Establishment of reference values for the lysine acetylation marker N
Topics: Adolescent; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Carnitine; Chromatography, Liquid; Citrulline; Creatinine; Female; Homoarginine; Humans; Lysine; Male; Middle Aged; Ornithine; Reference Values; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Young Adult | 2019 |
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.
Topics: Animals; Autoantibodies; Bone Marrow Cells; Cardiovascular Diseases; Carotid Artery Thrombosis; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Endothelium; Female; Humans; Hydrolases; Injections, Subcutaneous; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Ornithine; Phenotype; Protein-Arginine Deiminases; Stem Cells; Vasodilation | 2013 |
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2009 |
Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.
Topics: Aged; Anticholesteremic Agents; Apoptosis; Benzoates; Cardiovascular Agents; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Senescence; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Leukocytes, Mononuclear; Male; Middle Aged; Neovascularization, Physiologic; Nitrates; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Ornithine; Proto-Oncogene Proteins c-akt; Pyrroles; Stem Cells | 2011 |
Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.
Topics: Aged; Arginine; Cardiovascular Diseases; Chromatography; Citrulline; Coronary Angiography; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Models, Biological; Nitric Oxide; Ornithine; Proportional Hazards Models; Vascular Cell Adhesion Molecule-1 | 2011 |